2426 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2019
JOURNALCell death & disease
PREMIER AUTEURDumont A
TITREDocosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment.
ANNÉE2019
JOURNALCancers
PREMIER AUTEURElmallah MIY
TITREEpigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy.
ANNÉE2019
JOURNALCancer epidemiology
PREMIER AUTEURDrouillard A
TITRENet survival in recurrence-free colon cancer patients.
ANNÉE2019
JOURNALJournal of clinical oncology : official journal of the American Society of Clinical Oncology
PREMIER AUTEURFlippot R
TITRESafety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
ANNÉE2019
JOURNALBiochemical pharmacology
PREMIER AUTEURZeniou M
TITRETherapeutic considerations of PARP in stem cell biology: relevance in cancer and beyond.
ANNÉE2019
JOURNALRevue des maladies respiratoires
PREMIER AUTEURDebieuvre D
TITRE[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data].
ANNÉE2019
JOURNALRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PREMIER AUTEURVendrely V
TITREAnti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904).
ANNÉE2019
JOURNALCancers
PREMIER AUTEURJob S
TITREPreferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on -Driven Oncogenic Addiction.
ANNÉE2019
JOURNALEuropean journal of cancer (Oxford, England : 1990)
PREMIER AUTEURCouraud S
TITREClinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study.
ANNÉE2019
JOURNALClinical cancer research : an official journal of the American Association for Cancer Research
PREMIER AUTEUREberst G
TITREHealth-related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques